CRK Gene - CRK Proto-Oncogene, Adaptor Protein

Comprehensive biomedical resource for CRK: genomic data, expression, mutations, and disease associations.

Gene Information Card

Symbol CRK
Full Name CRK proto-oncogene, adaptor protein
Gene Type protein-coding
Chromosomal Location 17p13.3
NCBI Gene ID 1398 ncbi.nlm.nih.gov/gene/1398
Ensembl ID ENSG00000167193
UniProt ID P46108
OMIM ID 164762
HGNC ID 2362
Aliases CRKII, p38, CRK-I, CRK-II

Description

The CRK gene encodes a member of the CRK family of adaptor proteins that contain SH2 and SH3 domains. This protein is involved in multiple signaling pathways, including those regulating cell proliferation, migration, and differentiation. It interacts with tyrosine-phosphorylated proteins and mediates signal transduction from receptor tyrosine kinases to downstream effectors. CRK is implicated in various cancers and developmental processes.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Lung Cancer CRK overexpression enhances cell migration and invasion via integrin signaling PMID: 23454750
Breast Cancer CRK amplification and overexpression promote tumor growth and metastasis PMID: 25609832
Colorectal Cancer CRK upregulation correlates with poor prognosis and activates MAPK pathway PMID: 27121325
Glioblastoma CRK signaling through FAK and p130Cas drives invasion PMID: 21947069

Expression Profile

Tissue Expression
Tissue nTPM level
Lung 12.3 Medium
Breast 8.7 Low
Colon 15.1 Medium
Brain 6.2 Low
Liver 9.4 Low
Kidney 11.0 Medium
Cell Line Expression
Cell Line nTPM Notes
A549 (lung cancer) 18.5 High expression
MCF7 (breast cancer) 14.2 Medium expression
HCT116 (colorectal cancer) 22.1 High expression
U87MG (glioblastoma) 16.8 High expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.497G>A (p.Arg166Gln) Missense <0.1% Altered SH3 domain binding
c.112C>T (p.Arg38Trp) Missense <0.1% Reduced SH2 domain affinity
c.1A>G (p.Met1Val) Start loss <0.1% Loss of protein expression
c.345_346insA Frameshift <0.1% Truncated protein, loss of function
Mutation functional classification

Loss of Function (LOF)

Frameshift and start-loss mutations lead to truncated or absent protein, impairing adaptor function.

Gain of Function (GOF)

Missense mutations in SH2/SH3 domains may alter binding specificity, potentially enhancing oncogenic signaling.

Dominant Negative (DN)

Some mutations produce truncated proteins that interfere with wild-type CRK signaling.

Pathways

ErbB signaling pathway (KEGG: hsa04012)
Focal adhesion (KEGG: hsa04510)
Rap1 signaling pathway (KEGG: hsa04015)
Signaling by Receptor Tyrosine Kinases (Reactome: R-HSA-9006934)

Protein Summary

CRK is a 38 kDa adaptor protein composed of one SH2 domain and two SH3 domains (N-terminal and C-terminal). It lacks intrinsic enzymatic activity but mediates protein-protein interactions in signaling cascades. The SH2 domain binds phosphotyrosine motifs on activated receptors or docking proteins, while SH3 domains recruit proline-rich effectors such as C3G, DOCK1, and ABL1. CRK is ubiquitously expressed and plays roles in cell adhesion, migration, and proliferation. Alternative splicing generates isoforms CRK-I and CRK-II, with CRK-II containing an additional C-terminal SH3 domain.

Related Products

Product name Cat.No. Species Gene ID
CRK Knockout HEK293 Cell Line EDJ-KQ634 Human 1398 Details Get a Quote
CRK Knockout HCT 116 Cell Line EDJ-KQ19103 Human 1398 Details Get a Quote
CRK Knockout HeLa Cell Line EDJ-KQ19104 Human 1398 Details Get a Quote
CRK Knockout A-549 Cell Line EDJ-KQ61449 Human 1398 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: